Even as FDA, in response to requests from the U.S. Centers for Disease Control, issued Emergency Use Authorizations (EUAs) to make available to public health and medical personnel diagnostic and therapeutic tools to identify and respond to the swine flu virus, news broke that some states have not stockpiled sufficient supplies of these drugs to meet potential demand should swine flu truly reach epidemic proportions.

FDA issued these EUAs for the use of certain Relenza and Tamiflu antiviral products, and for the rRTPCR Swine Flu Panel diagnostic test.

The ...

Find more facts and information related to the article "Supplying flu drugs, developing vaccine pose ..."